收费全文 | 2706篇 |
免费 | 221篇 |
国内免费 | 6篇 |
耳鼻咽喉 | 12篇 |
儿科学 | 88篇 |
妇产科学 | 45篇 |
基础医学 | 355篇 |
口腔科学 | 44篇 |
临床医学 | 286篇 |
内科学 | 551篇 |
皮肤病学 | 32篇 |
神经病学 | 210篇 |
特种医学 | 301篇 |
外国民族医学 | 1篇 |
外科学 | 277篇 |
综合类 | 62篇 |
预防医学 | 251篇 |
眼科学 | 44篇 |
药学 | 262篇 |
中国医学 | 4篇 |
肿瘤学 | 108篇 |
2021年 | 44篇 |
2020年 | 24篇 |
2019年 | 31篇 |
2018年 | 64篇 |
2017年 | 30篇 |
2016年 | 43篇 |
2015年 | 50篇 |
2014年 | 76篇 |
2013年 | 97篇 |
2012年 | 141篇 |
2011年 | 113篇 |
2010年 | 99篇 |
2009年 | 98篇 |
2008年 | 112篇 |
2007年 | 120篇 |
2006年 | 129篇 |
2005年 | 108篇 |
2004年 | 112篇 |
2003年 | 103篇 |
2002年 | 91篇 |
2001年 | 77篇 |
2000年 | 75篇 |
1999年 | 67篇 |
1998年 | 61篇 |
1997年 | 57篇 |
1996年 | 57篇 |
1995年 | 64篇 |
1994年 | 40篇 |
1993年 | 41篇 |
1992年 | 50篇 |
1991年 | 61篇 |
1990年 | 51篇 |
1989年 | 56篇 |
1988年 | 46篇 |
1987年 | 37篇 |
1986年 | 34篇 |
1985年 | 27篇 |
1984年 | 28篇 |
1983年 | 27篇 |
1982年 | 24篇 |
1981年 | 25篇 |
1980年 | 24篇 |
1979年 | 26篇 |
1978年 | 21篇 |
1977年 | 14篇 |
1976年 | 17篇 |
1975年 | 17篇 |
1970年 | 10篇 |
1968年 | 11篇 |
1967年 | 11篇 |
Background
Human immunodeficiency virus infected individuals are prone to malnutrition due to increased energy requirements, enteropathy and increased catabolism. Trace elements such as zinc and selenium have major role in maintaining a healthy immune system. This study was designed to evaluate the nutritional status of Iranian subjects who were newly diagnosed with human immunodeficiency virus infection and to compare serum level of zinc and selenium in these patients with those of the sex and aged match healthy subjects. 相似文献Methods: Pooled data from three randomized, placebo-controlled studies (two 6-month; one 12-month) of 18 mg nalmefene (as-needed use) in alcohol-dependent patients looking at the total population (placebo n = 824, nalmefene n = 1123) and patients with high/very high drinking risk levels at screening and randomization (target population: placebo n = 374, nalmefene n = 450).
Results: In the study, 62.7% of patients on placebo and 74.7% on nalmefene in the total population had treatment-emergent adverse events (TEAEs). Fourty-seven (5.9%) on placebo and 149 (13.0%) on nalmefene dropped out due to TEAEs. Thirty-five (4.4%) on placebo and 57 (5.0%) on nalmefene had serious adverse events. Tolerability and safety were similar in the target population and total population. Most frequent TEAEs were transient, mainly occurring at treatment initiation. There was no difference in tolerability and safety if nalmefene was taken daily or intermittently; no signal of increased risk of suicide-related behavior with nalmefene. The higher incidence of psychiatric events in the nalmefene group was mainly due to the TEAE of confusional state.
Conclusions: Although there was a higher incidence of TEAEs and TEAEs leading to dropout, nalmefene was well-tolerated and no major safety issues were identified. 相似文献